(Q44770265)

6 December 2017

title

Unbalanced statistical analysis of combined divalproex and antipsychotic therapy for schizophrenia (English)

1 reference

6 December 2017

0 references

1 reference

Laura S Boylan

1

0 references

author name string

Daniel L Labovitz

series ordinal

2

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

6 December 2017

published in

Neuropsychopharmacology

1 reference

6 December 2017

volume

29

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

636; author reply 637-8

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300368

6 December 2017

exact match

0 references

cites work

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300368

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300368

Combined treatment of schizophrenic psychoses with haloperidol and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300368

Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300368

Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300368

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1300368

1 reference

6 December 2017

1 reference